Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Tjia

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|March 10, 1998
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesV A Eagling, J F Tjia, D J Back
British Journal of Clinical Pharmacology|July 1, 1988
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolinesD J Back, J F Tjia, J Karbwang, et al.
British Journal of Clinical Pharmacology|March 1, 1992
Metabolism of 2',3'-dideoxyinosine (ddI) in human bloodD J Back, S Ormesher, J F Tjia, et al.
British Journal of Clinical Pharmacology|October 1, 1983
Sulphaphenazole and drug oxidation in manD B Back, B K Park, J F Tjia, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1985
The effect of some benzimidazoles on the disposition of antipyrine and tolbutamide from the rat isolated perfused liverS A Ward, G W Mihaly, J F Tjia, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1991
Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomesD J Back, R Houlgrave, J F Tjia, et al.
Lancet (London, England)|August 19, 1989
Cyclosporin metabolites and neurotoxicityA K Trull, K K Tan, N B Roberts, et al.
Analytical Biochemistry|June 10, 2000
Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasmaH R Wiltshire, B G Wiltshire, A F Clarke, et al.
Pharmacogenetics|April 20, 1999
The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylationH J Gill, J F Tjia, N R Kitteringham, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1992
The in-vitro mucosal conjugation of ethinyloestradiol and the bioavailability of oral contraceptive steroids in patients with treated and untreated coeliac diseaseS F Grimmer, D J Back, M L Orme, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|March 10, 1998
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesV A Eagling, J F Tjia, D J Back
British Journal of Clinical Pharmacology|July 1, 1988
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolinesD J Back, J F Tjia, J Karbwang, et al.
British Journal of Clinical Pharmacology|March 1, 1992
Metabolism of 2',3'-dideoxyinosine (ddI) in human bloodD J Back, S Ormesher, J F Tjia, et al.
British Journal of Clinical Pharmacology|October 1, 1983
Sulphaphenazole and drug oxidation in manD B Back, B K Park, J F Tjia, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1985
The effect of some benzimidazoles on the disposition of antipyrine and tolbutamide from the rat isolated perfused liverS A Ward, G W Mihaly, J F Tjia, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 1, 1991
Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomesD J Back, R Houlgrave, J F Tjia, et al.
Lancet (London, England)|August 19, 1989
Cyclosporin metabolites and neurotoxicityA K Trull, K K Tan, N B Roberts, et al.
Analytical Biochemistry|June 10, 2000
Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasmaH R Wiltshire, B G Wiltshire, A F Clarke, et al.
Pharmacogenetics|April 20, 1999
The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylationH J Gill, J F Tjia, N R Kitteringham, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1992
The in-vitro mucosal conjugation of ethinyloestradiol and the bioavailability of oral contraceptive steroids in patients with treated and untreated coeliac diseaseS F Grimmer, D J Back, M L Orme, et al.
Pageof 3